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Using a computer program designed to detect evolutionary relationships between proteins, I find that exon 
2 of rabbit uteroglobin, a progesterone binder, and part of myosin alkali light chain have a comparison 
score that is 7.2 standard deviations higher than that obtained with a comparison of randomized sequences 
of these proteins. The probability (p) of getting this score by chance is less than 10-12. This theoretical find- 
ing that these sequences are similar has led to the experimental finding that copper, calcium and the tranquil- 
izer trifluoperazine, a calmodulin binding ligand, affect progesterone binding to uteroglobin. 
Calcium-modulated protein Myosin Uteroglobin 
1. INTRODUCTION 
Myosin alkali light chain, troponin C, par- 
valbumin and calmodulin belong to a family of 
calcium-modulated proteins [l-5]. These proteins 
have no apparent functional relationship to steroid 
hormone binding proteins such as rabbit 
uteroglobin [&lo] and rat prostatic steroid 
binding protein [ 1 l- 141. Serendipitously, I 
discovered that the primary amino acid sequences 
of uteroglobin and prostatic steroid binding pro- 
tein were similar to those of calcium-modulated 
proteins while exploring the hypothesis that steroid 
hormone binding proteins, including uteroglobin 
and prostatic steroid binding protein, contain 
some chemical structures that resemble those 
found in serine proteases [1% 171. That hypothesis 
led me to compare the amino acid sequences of 
several steroid hormone binding proteins with 
those of serine proteases, using computer pro- 
grams developed for that purpose at the National 
Biomedical Research Foundation [18-221. As a 
control for those comparisons, I compared rabbit 
uteroglobin with calmodulin and unexpectedly 
found that the primary amino acid sequences of 
these 2 proteins were similar. More comprehensive 
Progesterone Copper Prostatic steroid binding protein 
computer-based analyses of uteroglobin and pro- 
static steroid binding protein with other calcium- 
modulated proteins showed that among these latter 
proteins, myosin alkali light chain 1 of rabbit fast 
skeletal muscle is most similar to rabbit 
uteroglobin and troponin C is most similar to rat 
prostatic steroid binding protein. These theoretical 
results stimulated me to search for other 
similarities between uteroglobin and calcium- 
modulated proteins, which led to the novel ex- 
perimental finding that copper, calcium, and the 
tranquilizer trifluoperazine, a calmodulin binding 
ligand, affect progesterone binding to uteroglobin. 
Here I report the details of these theoretical and 
experimental studies. 
2. MATERIALS AND METHODS 
2.1. Computer analyses 
The Relate program compares all possible 
segments of a given length from one sequence with 
all segments of the same length from a second se- 
quence [ 18-221. A segment score is accumulated 
from the pair scores of the amino acids occupying 
corresponding positions with the 2 segments. The 
pair scores are specified using an empirically de- 
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rived muta~on data matrix [ 18-221. The mean of 
a number of highest scores is determined for the 
given sequences and for 250 comparisons of ran- 
dom permutations of the sequences. The segment 
comparison score is calculated as the difference 
between the mean of the real sequences and the 
averaged value determined from the randomized 
sequences divided by the standard deviation (SD) 
of the values of the randomized sequences. The 
segment comparison score is thus expressed in SD 
units. A score greater than 5 SD units (p less than 
2.8 x lo-‘) indicates that the sequences of the 2 
proteins are similar and this suggests that the pro- 
teins may also have similarities in their biological 
activities. Scores between 3 SD @ c 10W3) and S SD 
@ < 2.8 x lo-‘) support a relationship between the 
sequences of the 2 proteins if there are other in- 
dications such as similarity of function. 
2.2. Progesterone binding to rabbit uteroglobin 
Uteroglobin was extracted from rabbit uteri by 
homogenization with 1 g tissue/4 ml buffer with a 
polytron homogenizer. The homogenate was cen- 
trifuged first for 15 min at 10000 x g and then the 
resulting supernatant was centrifuged for 1 h at 
190000 x g. This cytosol was partially purified by 
filtration on Sephadex G-75, which separated 
uteroglobin from various proteins including cor- 
ticosterone binding globulin and progesterone 
receptor [7,8]. The binding of progesterone to 
Table 1 
Segment comparison scores of exon 2 of rabbit 
uteroglobin and calcium-modulated proteins 
Protein Score p 
(SD) 
Rabbit myosin alkali light chain 
(residues 109-168) 7.2 < lo-‘2 
Chicken myosin alkali light chain 
(residues 108-167) 6.6 4 x IO-” 
Calmodulin (residues 1-5 1) 4.5 3.4 x 1o-6 
Rabbit troponin C, skeletal muscle 
(residues l-58) 4.2 1o-5 
These segment comparison scores were obtained using 
the ReIate program (segment length 20 amino acids) and 
250 random permutations of the sequences for statistical 
analysis 
uteroglobin was determined by incubation of 
uteroglobin at pH 7.8 in buffer consisting of 
SO mM Hepes, SO mM NaCl, 10 mM dithiothrei- 
tol, and 6.3 x lo-’ M H-progesterone for 15 min 
at 37°C. Then aliquots of the sample were added 
to tubes containing various compounds or 3 x 
lo-’ M unlabeled progesterone (to determine non- 
specific binding). These samples were incubated 
for 1 h at 22°C and then for 1 h at 0°C. Bound 
steroid was determined using a dextran-coated 
charsoal technique similar to that described by 
Beato 1231. Each sample was done in duplicate. 
Variation was less than 10%. The stock copper 
chloride solution contained nitrilotriacetic acid at 
10% molar excess. Nitrilotriacetic acid is a ‘soft’ 
chelator that prevents polymerization of the cop- 
per ion 1241. 
3. RESULTS AND DISCUSSION 
3.1. Some properties of uteroglobin and prostatic 
steroid binding protein 
Rabbit uteroglobin consists of 2 identical 
poi~eptides (Mr -8000) joined by 2 disulfide 
bridges [2S-271. Progesterone both induces 
uteroglobin synthesis in rabbit uterus and binds to 
uteroglobin (& -1 PM). Rat prostatic steroid 
binding protein (PSBP) is a tetramer consisting of 
2 subunits: an A subunit containing polypeptides 
Cl (M* -10200) and C3 (&& -8600) and a B 
subunit containing CZ (Iw, -1OSOO) and C3 
[28-3 11. Androgens both induce prostatic steroid 
binding protein synthesis and bind to prostatic 
steroid binding protein (& -1 FM). Uteroglobin 
and PSBP’s Cr and CZ polypeptides exhibit amino 
acid sequence homology [32] and similar gene 
structures (M. Beato and M. Parker, personal 
communication). Because synthesis of uteroglobin 
and PSBP is induced by steroids, these proteins are 
useful model systems for studying gene regulation, 
in addition to their importance in reproductive 
biology. 
Myosin alkali light chain, troponin G and par- 
valbumin were originally found in muscle cells. In 
the last few years these proteins have been found 
in many other types of cells. Most of these proteins 
bind calcium and/or participate in processes that 
are calcium regulated. Calcium-modulated pro- 
teins appear to have evolved from an ancestor of 
about 40 residues by gene duplication [l-4,33]. 
189 
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3.2. Computer-based similarity between 
uteroglobin and myosin alkali light chain 
A preliminary computer analysis using the 
Relate program [l&22] indicated that residues 
l-60 (exon 2) of uteroglobin [27,34] were similar 
to myosin alkali light chain. Table 1 summarizes 
the results of a Relate analysis of exon 2 of 
uteroglobin with myosin alkali light chain, 
calmodulin and troponin C, and in parentheses the 
regions in these proteins that have the closest rela- 
tionship to exon 2 of uteroglobin are described. 
The Relate analysis comparison of exon 2 of 
uteroglobin and rabbit myosin alkali light chain 
gives a score that is 7.2 SD higher than the score 
found with randomized sequences of these pro- 
teins. The probability (p) of getting a score of 7.2 
SD by chance is < lo- ‘* The alignment of residues . 
l-60 (exon 2) of uteroglobin and residues 109-168 
of the myosin alkali light chain is shown in fig.1. 
Based on Nabeshima et al. [36] report of the gene 
structure of myosin alkali light chain in chicken, 
fig. 1 shows an alignment of part of exons 6 and 7 
of myosin alkali light chain with exon 2 of 
uteroglobin. 
3.3. EF-hand structure analysis of uteroglobin 
To further explore the relationship between 
uteroglobin and calcium-modulated proteins, exon 
2 of uteroglobin was analyzed in terms of the EF- 
hand structure. This structure has been useful in 
elucidating how calcium-modulated proteins bind 
calcium [3,35]. Fig.1 shows the nomenclaturi of 
the EF-hand superimposed upon the alignment of 
uteroglobin and myosin alkali light chain. As 
1 
UTEROGLOGIN 
ALKALI LIGHT 
109 127 
n n n n X V 2 G I -x 39 -2 
UTEROGLOGIN [$r-; Glu - Thr Asp . Thr - Met - Lys - Asp . Ala 
I 
MYOSIN 1 ’ 
ALKALI LIGHT 1 : 
CHAIN LP_hheJ Val - Glu Gly . Asp - Thr - Val - Gly - Met 
147 
UTEROGLOGIN 
Fig.1. Alignment of residues l-60 of rabbit uteroglobin and residues 109-168 of rabbit myosin alkali light chain. 
Residue numbering refers to the mature sequence of these proteins. Solid boxes show identities and the dotted boxes 
show replacements that both have a single nucleotide difference and are frequently observed in families of proteins. 
The EF-hand model developed by Kretsinger [3,35] for analyzing the calcium binding domain of calcium-modulated 
proteins is notated above the uteroglobin sequence. a-Helix E starts at residue 20. The position of hydrophobic residues 
that are conserved at the interior of the LY helix are notated with n. The positions where amino acid side chains provide 
oxygen to coordinate with calcium are notated X, Y, Z, -X and -Z. Amino acids that can do this are Asp, Asn, Glu, 
Gln, Ser or Thr. An invariant glycine following Z and isoleucine preceding - X are also shown. In this EF-hand domain, 
the uteroglobin sequence at X, Y, Z and - Z has oxygen ligands that could coordinate with calcium. At the hydrophobic 
positions of the cr helix, uteroglobin has amino acids that are either identical to or conservative replacements of 
corresponding residues on myosin alkali light chain. The alanine residue at -X would not provide an oxygen to 
coordinate with Ca2’. This and the absence of the glycine and isoleucine residues, which are conserved in calcium 
binding EF-hand domains, in uteroglobin make it unlikely that this protein has a high affinity for calcium. 
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shown in fig. 1 the amino acid residues at X, Y, Z, 
-Z of uteroglobin have oxygen containing side 
chains that can coordinate with calcium. Also, 
fig.1 shows that both proteins lack an oxygen- 
coordinating residue at the - X coordinate and the 
glycine and isoleucine residues that are conserved 
in EF-hand domains that bind calcium with high 
affinity [3,35]. The positions in the interior of the 
2 LY helices on uteroglobin that have hydrophobic 
residues are either identities or conservative 
replacements of corresponding residues in myosin 
alkali light chain. These correspondences in the 
EF-hand structures of uteroglobin and myosin 
alkali light chain provide additional evidence that 
these proteins are similar. Myosin alkali light chain 
does not bind calcium with high affinity even 
though it is homologous to proteins that do. The 
EF-hand analysis predicts that uteroglobin would 
not have a high affinity for calcium. Since the gene 
for uteroglobin has been cloned [27,34], it is possi- 
ble to use recombinant DNA techniques to con- 
struct a uteroglobin molecule with residues that 
fulfill the EF-hand requirements for binding 
calcium with high affinity. It would be interesting 
to know if this uteroglobin variant bound calcium 
and progesterone. 
The comparison score of 7.2 SD (p < 10-12), 
which was obtained from the computer analysis of 
the primary amino acid sequences of uteroglobin 
and myosin alkali light chain, suggests that these 2 
proteins are similar. The EF-hand structure in 
these proteins is also similar. These analyses do not 
determine whether these proteins are derived from 
a common ancestor or whether the similarities be- 
tween uteroglobin and myosin alkali light chain are 
the result of convergent evolution. However, in 
either case, the similarities between these proteins 
have sufficient statistical substance to suggest ad- 
ditional computer analyses and experimental 
studies, which have interesting implications for the 
evolution and function of uteroglobin and rat 
prostatic steroid binding protein. 
3.4. Computer-based similarity between the C3 
chain of rat prostatic steroid binding protein 
and troponin C 
Because rabbit uteroglobin is related to the Cr 
and CZ chains of rat prostatic steroid binding pro- 
tein [32], it seemed useful to compare the amino 
acid sequences of Cl and CZ, with those of 
calcium-modulated proteins. C3 was used as a con- 
trol because its amino acid sequence does not show 
similarity with Cl and Cz [32]. The Relate analysis 
comparison scores for Cl and Cz with parvalbumin 
were at the borderline for significance. For exam- 
ple, the Relate comparison of Cl and rabbit par- 
valbumin gave a score of 3 SD. The other calcium- 
modulated proteins had lower scores. Unexpected- 
ly, the amino acid sequence of ‘the control pro- 
tein’C3 [29,37,38] appeared to be similar to that of 
frog t;oponin C (6.5 SD, p = 4 x 10-l’). As would 
be expected, C3 shows some similarity to other 
calcium-modulated proteins. Table 2 summarizes 
the results of the comparisons of C:, with different 
calcium-modulated proteins. The finding that both 
uteroglobin and C3 have amino acid sequences that 
are similar to calcium-modulated proteins and the 
similarity among uteroglobin, Ci and Cz suggests 
that uteroglobin, Ci, Cz and C’s have evolved from 
a common ancestor. Interestingly, Parker et al. 
[37,38] proposed that C3 was related to Ci and CZ 
on the basis of similarities of their gene structure. 
Further, W. Barker (personal communication) has 
found that a computer analysis with the Align pro- 
gram of the entire uteroglobin and C3 amino acid 
sequences (including the signal peptide) indicate 
that these proteins are similar. W. Heyns (personal 
communication) reached a similar conclusion. 
Their findings and the results reported here sup- 
port the proposal of Parker et al. that Ci, C2 and 
C3 evolved from a common ancestral gene. 
Table 2 
Segment comparison scores of exon 2 of Cs chain of rat 
prostatic steroid binding protein and calcium-modulated 
proteins 
Protein Score p 
(SD) 
Frog troponin C (residues 55-117) 6.5 4 x lo-” 
Calmodulin (residues 45-107) 4.8 1o-6 
Rabbit myosin alkali light chain 
(residues 9-7 1) 4.0 3 x 10-s 
Thornback ray parvalbumin 
(residues 23-85) 4.2 10-5 
These segment comparison scores were obtained using 
the Relate program (segment length 30 amino acids) and 
250 random permutations of the sequences for statistical 
analysis 
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Uteroglobin and prostatic steroid binding pro- 
tein belong to a family of proteins whose functions 
are still being elucidated [32,39]. Uteroglobin is 
important in reproductive processes [9,10,40]. 
Estrogen mustards, which bind to prostatic steroid 
binding protein, are used in treating cancer of the 
prostate [41,42]. Like other steroid hormone 
binding proteins, uteroglobin and prostatic steroid 
binding protein contain a nucleophilic site that 
both recognizes inhibitors and substrates of serine 
proteases and influences steroid hormone binding 
(M. Baker, unpublished). The function of this site 
is not established. The similarity between the 
amino acid sequences of uteroglobin, prostatic 
steroid binding protein and calcium-modulated 
proteins presented in tables 1 and 2 suggests ome 
interesting experiments that could provide clues 
for elucidating the functions of these proteins. 
These experiments include determining if 
uteroglobin and prostatic steroid binding protein 
bind calcium or other metal ions or if phosphoryla- 
tion of uteroglobin and prostatic steroid binding 
protein is important in their functioning. On the 
other side of the coin, it would be interesting to 
determine if steroid hormones and/or electrophilic 
compounds that are inhibitors and substrates of 
serine proteases interact with calcium-modulated 
proteins, even though these proteins are unlikely to 
have the same functions as uteroglobin and 
prostatic steroid binding protein. 
3.5. Effect of some divalent metal ions on 
progesterone binding to uteroglobin 
To begin to explore these possibilities, the effect 
of divalent metal ions such as calcium, magnesium 
and copper on progesterone binding to rabbit 
uteroglobin was studied. Studies from Beato’s 
laboratory [23,43,44] show that treatment of 
uteroglobin with agents such as dithiothreitol, to 
reduce the 2 disulfide bridges in uteroglobin, in- 
crease its affinity for progesterone by over lo-fold 
compared to the oxidized dimer. Also, it appears 
that the steroid binding species of uteroglobin is a 
tetramer [44]. As shown in table 3a, neither 5 mM 
calcium nor 5 mM magnesium had an effect on 
progesterone binding to uteroglobin. Unexpected- 
ly, 0.5 mM CuCl2 complexed with 0.55 mM 
nitrilotriacetic acid, a soft chelator [24], increased 
specific [3H]progesterone binding to uteroglobin 
from 10000 to 40000 cpm/ml (table 3a). Copper 
192 
interacts with a histidine residue on albumin to 
promote its polymerization [45]. Analogously, 
copper could interact with histidine and/or cys- 
teine on uteroglobin to stabilize the progesterone 
binding conformation. Uteroglobin in the presence 
of copper appears to bind calcium and magnesium 
with low affinity. Adding 5.0 mM CaC12 to the 
sample with 0.5 mM CuC12 reduces specific 
[3H]progesterone binding to uteroglobin to 
18000 cpm/ml (table 3b). And when MgCl2 is 
substituted for CaClz in this experiment, specific 
[3H]progesterone binding is decreased to 
33000 cpm/ml. Thus calcium is more effective 
than magnesium in antagonizing the effect of 
CuClz on progesterone binding to uteroglobin. 
This suggests that there is a specificity for calcium 
in its interaction with uteroglobin. This relatively 
low affinity of calcium for uteroglobin, at least 
compared to troponin C, calmodulin and par- 
valbumin, is what would be expected from the EF- 
hand analysis of uteroglobin (fig.1). 
The tranquilizer trifluoperazine binds to 
calmodulin with PM affinity [45]. Resins with 
covalently attached trifluoperazine are used to 
purify calmodulin by affinity chromatography. 
Trifluoperazine inhibits progesterone binding to 
uteroglobin (table 3b). The binding of 
trifluoperazine by uteroglobin provides another 
similarity between this protein and calmodulin. 
The findings presented in table 3 showing that 
copper, calcium and trifluoperazine influence pro- 
gesterone binding to uteroglobin may have 
biological implications. In particular the possibili- 
ty that copper intrauterine devices could supply 
copper ions that could interact with proteins from 
the uterus and semen that are related to 
uteroglobin should be considered. In this regard, it 
is interesting that in 1976 Daniel reported that 
neutron-activation analysis of electrophoretically 
purified uterine washings showed that copper was 
preferentially associated with a uteroglobin con- 
taining fraction [lo]. 
Thus, the computer analysis, which shows that 
exon 2 of uteroglobin is similar to calcium- 
modulated proteins, has led to experiments how- 
ing that metal ions and trifluoperazine affect the 
progesterone binding to uteroglobin. It will be im- 
portant to see whether the other questions raised 
from the computer analysis reported here also 
yield interesting experimental findings. 
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Table 3 
Effect of metal ions and trifluoperazine on [3H]progesterone binding to rabbit 
uteroglobin 
Sample 
(a) 
Control 
5.0 mM CaClz 
5.0 mM MgClz 
12.5 PM trifluoperazine 
1.0 mM CuC12 
0.5 mM CuCl2 
0.25 mM CuClz 
Specifically bound % of % of 
[‘HIprogesterone control 0.5 mM CuC12 
(cpm/ml) sample 
9730 100 
9780 100 
9070 93 
7685 79 
36835 375 92 
40225 410 100 
33315 340 83 
(b) Incubated with: 
0.5 mM CuClz and 
5.0 mM CaCl2 
5.0 mM MgClz 
12.5 pM trifluoperazine 
12.5 pM trifluoperazine + 
17645 180 44 
33070 340 82 
28 360 290 70 
5 mM CaCl2 11600 120 29 
Uteroglobin was incubated at pH 7.8 in buffer consisting of 50 mM Hepes, 
50 mM NaCl, 10 mM dithiothreitol and 6.3 x 10m8 [3H]progesterone for 15 min 
at 37°C. Then aliquots of the sample were added to tubes containing various 
compounds, or 3 x 10m5 M unlabeled progesterone (to determine non-specific 
binding). These samples were incubated for 1 h at 22°C and then for 1 h at 0°C. 
Bound steroid was determined using a dextran-coated charcoal technique 
similar to that described by Beato [23]. Each sample was done in duplicate. 
Variation was less than 10%. The stock copper chloride solution contained 
nitrilotriacetic acid at 10% molar excess. Nitrilotriacetic acid is a ‘soft’ chelator 
that prevents polymerization of the copper ion [24] 
ACKNOWLEDGEMENTS 
I thank Dr Robert Kretsinger for valuable com- 
ments about preliminary versions of this 
manuscript and metal ion mavin Paul Saltman for 
advice. This research was supported by NIH grant 
HD 14988 and a special grant from Marvin 
Weissberg. 
REFERENCES 
[l] Barker, W.C., Ketcham, L.K. and Dayhoff, M.O. 
(1978) in: Atlas of Protein Sequence and Structure 
(Dayhoff, M.O. ed.) ~01.5, suppl.3, pp.273-283, 
National Biochemical Research Foundation, 
Washington, DC. 
121 
[31 
[41 
[51 
El 
171 
181 
191 
[lOI 
Goodman, M., Pechere, J.-F., Haiech, J. and 
Demaille, J.G. (1979) J. Mol. Evol. 13, 331-352. 
Kretsinger, R.H. (1980) CRC Crit. Rev. Biochem. 
8, 119-174. 
Collins, J.H. (1984) Biochem. Biophys. Res. Com- 
mun. 58, 301-308. 
Cheung, W.Y. (1980) Science 207, 19-27. 
Krishnan, R.S. and Daniel, J.C. (1967) Science 
158, 490-492. 
Fridlansky, F. and Milgrom, E. (1976) 
Endocrinology 99, 1244-1251. 
Beato, M., Arneman, T. and Voss, H. J. (1977) J. 
Steroid Biochem. 8, 725-730. 
Beier, H.M. (1976) J. Reprod. Fert. Suppl. 25, 
53-69. 
Daniel, J.G. jr (1976) J. Reprod. Fert. Suppl. 25, 
71-83. 
193 
Volume 189, number 2 FEBS LETTERS September 1985 
[l l] Karsnia, R., Wyss, R.H., Heinrichs, W.L. and 1281 Heyns, W., Peeters, B., Mous, J., Rombauts, W. 
Herrmann, W.L. (1969) Endocrinology 84, and DeMoor, P. (1978) Eur. J. Biochem. 89, 
1238-1246. 181-186. 
[12] Fang, S. and Liao, S.J. (1971) J. Biol. Chem. 246, 
16-24. 
[13] Heyns, W. and De Moor, P. (1977) Eur. J. Bio- 
them. 78, 221-230. 
[ 141 Lea, O.A., Petrusz, P. and French, F.S. (1979) J. 
Biol. Chem. 254, 6196-6202. 
[15] Baker, M.E., Frecker, D.G.N. and Fanestil, D.D. 
(1982) J. Steroid Biochem. 16, 503-507. 
[16] Baker and Terry, L.S. (1983) Steroids 42, 593-602. 
[17] Baker, M.E. (1984) FEBS Lett. 175, 41-44. 
[18] Dayhoff, M.O., Eck, R.V. and Park, C.V. (1972) 
in: Atlas of Protein Sequence and Structure 
(Dayhoff, M.O. ed.) ~01.5, pp.89-99, National 
Biomedical Research Foundation, Washington, 
DC. 
[29] Peeters, B., Rombauts, W., Mous, J. and Heyns, 
W. (1981) Eur. J. Biochem. 115, 115-121. 
[30] Chen, C., Schilling, K., Hiipakka, R.A., Huang, I. 
and Liao, S. (1982) J. Biol. Chem. 257, 116-121. 
[31] Parker, M.G., Needham, M. and White, R. (1982) 
Nature 298, 92-94. 
[32] Baker, M.E. (1983) Biochem. Biophys. Res. Com- 
mun. 114, 325-330. 
(331 Baba, M.L., Goodman, M., Cohn, J.B., Dumaille, 
J.G. and Matsuda, G. (1984) Mol. Biol. Evol. 1, 
442-455. 
[19] Barker, W.C. and Dayhoff, M.O. (1972) in: Atlas 
of Protein Sequence and Structure (Dayhoff, M.O. 
ed.) ~01.5, pp.lOl-110, National Biomedical 
Research Foundation, Washington, DC. 
[20] Dayhoff, M.O. (1978) in: Atlas of Protein 
Sequence and Structure (Dayhoff, M.O. ed.) ~01.5, 
suppl.3, pp. l-8, National Biomedical Research 
Foundation, Washington, DC. 
[21] Schwartz, R.M. and Dayhoff, M.O. (1978) in: 
Atlas of Protein Sequence and Structure (Dayhoff, 
M.O. ed.) ~01.5, suppl.3, pp.353-358, National 
Biomedical Research Foundation, Washington, 
DC. 
[34] Bailly, A., Atger, M., Atger, P., Cerbon, M.-A., 
Alizon, M., Hai, M.T.V., Logeat, F. and Milgrom, 
E. (1983) J. Biol. Chem. 258, 10384-10389. 
[35] Tufty, R.M. and Kretsinger, R.H. (1975) Science 
187, 167-169. 
[36] Nabeshima, Y., Fujii-Kuriyama, Y., Muramatsu, 
M. and Ogata, K. (1984) Nature 308, 333-338. 
[37] Parker, M.G., White, R., Hurst, H., Needham, M. 
and Tilly, R. (1983) J. Biol. Chem. 258, 12-15. 
[38] Hurst, H.C. and Parker, M.G. (1983) EMBO J. 2, 
769-774. 
[39] Baker, M.E. (1984) Biochem. Biophys. Res. Com- 
mun. 122, 662-667. 
[22] Barker, W.C. and Dayhoff, M.O. (1982) Proc. 
Natl. Acad. Sci. USA 79, 2836-2839. 
[23] Beato, M. (1976) J. Steroid Biochem. 7, 327-334. 
[24] Bates, G.W., Billups, C. and Saltman, P. (1967) J. 
Biol. Chem. 242, 2810-2815. 
[25] Pontstingl, H., Nieto, A. and Beato, M. (1978) 
Biochemistry 17, 3908-3912. 
[26] Popp, R.A., Foresman, K.R., Wise, L.D. and 
Daniel, J.C. jr (1978) Proc. Natl. Acad. Sci. USA 
75, 5516-5519. 
[40] Mukherjee, D.C., Agrawal, A.K., Manjunath, R. 
and Mukherjee, A.B. (1983) Science 219, 989-991. 
[41] Forsgren, B., Bjork, P., Carlstrom, K., 
Gustafsson, J.-A., Pousete, A. and Hogberg, B. 
(1979) Proc. Natl. Acad. Sci. USA 76, 3149-3153. 
[42] Jonsson, G., Hoberg, B. and Nilsson, T. (1977) 
Stand. J. Urol. Nephrol. 11, 231-238. 
[43] Beato, M., Arnemann, J. and Voss, H.-J. (1977) J. 
Ster. Biochem. 8, 725-730. 
[44] Temussi, P.A., Tancredi, T., Puigdomenech, P., 
Saavedra, A. and Beato, M. (1980) Biochemistry 
19, 3287-3293. 
[27] Menne, C., Suske, G., Arnemann, J., Wenz, A.C., 
Cato, B. and Beato, M. (1982) Proc. Natl. Acad. 
Sci. USA 79, 4853-4857. 
[45] Osterberg, R., Branegard, R., Ligaarden, R. and 
Sarkar, B. (1975) Bioinorganic Chem. 5, 149-165. 
[46] Levin, R.M. and Weiss, B. (1977) Mol. Pharmacol. 
13, 690-697. 
194 
